Genenta Science
  • who we are
  • our companies
  • stories
  • investors
Select Page
← Press Coverage

BioCentury Extra

Gene therapy newco Genenta raises EUR 6.2M toward series A

23 January 2015
Apri PDF in una nuova scheda ↗
CONTACT
NEWSROOM
© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963